Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement
JAMA Network Open · 12.05.2026 · 9 (5) · e2616780
DOI: 10.1001/jamanetworkopen.2026.16780 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.05.2026. Verfasst von Michelle S Rockwell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family & Community Medicine, Virginia Tech Carilion School of Medicine, Roanoke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cohort study compares prescription rates of a combination ivermectin-benzimidazole regimen for cancer before vs after a celebrity endorsement.
Autor:innen und Institutionen
- Department of Family & Community Medicine, Virginia Tech Carilion School of Medicine, Roanoke.
- Division of Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles.
- Center for Value Based Insurance Design, University of Michigan, Ann Arbor.
Zitieren
APA
Rockwell, M. S., Kahn, K. L., Fendrick, A. M., Vangala, S., & Mafi, J. N. (2026). Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement. JAMA Network Open, 9(5), e2616780. https://doi.org/10.1001/jamanetworkopen.2026.16780
Vancouver
Rockwell MS, Kahn KL, Fendrick AM, Vangala S, Mafi JN. Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement. JAMA Network Open. 2026;9(5):e2616780. doi:10.1001/jamanetworkopen.2026.16780
BibTeX
@article{Rockwell2026,
author = {Rockwell, Michelle S and Kahn, Katherine L and Fendrick, A Mark and Vangala, Sitaram and Mafi, John N},
title = {Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {5},
pages = {e2616780},
doi = {10.1001/jamanetworkopen.2026.16780}
}
EUVIMED